VISTIN PHARMA ASA NK 1VISTIN PHARMA ASA NK 1VISTIN PHARMA ASA NK 1

VISTIN PHARMA ASA NK 1

No trades
See on Supercharts
Next report date
Report period
Q2 2024
EPS estimate
Revenue estimate
Market capitalization
‪90.02 M‬EUR
‪4.06 M‬EUR
‪38.73 M‬EUR
‪19.57 M‬
Beta (1Y)
0.51

About VISTIN PHARMA ASA

CEO
Magnus Tolleshaug
Headquarters
Oslo
Website
Employees (FY)
77
Founded
2015
FIGI
BBG00N0NS1J5
Vistin Pharma ASA engages in the manufacture and sale of metformin products. It offers Metformin HCI and Metformin DC. It operates through the following segments: Pharmaceuticals, Energy Trading, and Headquarter and Other. The company was founded on March 6, 2015 and is headquartered in Oslo, Norway.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange VISTIN PHARMA ASA NK 1 stocks are traded under the ticker VP4.
VISTIN PHARMA ASA NK 1 is going to release the next earnings report on Aug 23, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track VISTIN PHARMA ASA NK 1 financials in yearly and quarterly reports right on TradingView.
VP4 net income for the last quarter is ‪655.62 K‬ EUR, while the quarter before that showed ‪1.60 M‬ EUR of net income which accounts for −59.13% change. Track more VISTIN PHARMA ASA NK 1 financial stats to get the full picture.
Like other stocks, VP4 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VISTIN PHARMA ASA NK 1 stock right from TradingView charts — choose your broker and connect to your account.
VP4 reached its all-time high on Apr 12, 2021 with the price of 2.720 EUR, and its all-time low was 1.080 EUR and was reached on Oct 3, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 27, 2024, the company has 77.00 employees. See our rating of the largest employees — is VISTIN PHARMA ASA NK 1 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VISTIN PHARMA ASA NK 1 EBITDA is ‪7.90 M‬ EUR, and current EBITDA margin is 19.06%. See more stats in VISTIN PHARMA ASA NK 1 financial statements.